STARLIMS’s advanced web-based applications help laboratories effectively store, retrieve and evaluate data and so are designed for a multitude of laboratory conditions operating across numerous scientific, clinical and industrial disciplines. Michael, executive vice president, diagnostics products, Abbott. ‘The acquisition enables us to supply a common informatics framework across all of our diagnostics businesses and, important equally, can help accelerate STARLIMS’s growth strategy in the non-diagnostics marketplace segments it currently serves.’ SOURCE Abbott.. Abbott acquires STARLIMS Technology for $123M Related StoriesOJ Bio in Medica 2015 – Stage of Care diagnostics' role in reducing antibiotics prescribingRapid, award winning diagnostic lab tests to be shown at MEDICATransitioning infrared imaging into scientific use: an interview with Dr Matthew BakerAbbott announced today that it has finished its $123 million acquisition of STARLIMS Technology Ltd., a innovator in laboratory information administration systems.In case you are troubled by adult starting point acne, first consult your doctor. He or she may have a hormonal adult acne treatment that will help. In case you have adult acne and it is serious or causes you discomfort do not hesitate to speak to your doctor and discuss possible medical treatment of your acne.. Alnylam Pharmaceuticals initiates dosing in Phase I human clinical research with ALN-TTR01 Alnylam Pharmaceuticals, Inc. , a respected RNAi therapeutics company, announced today it provides initiated dosing in a Stage I human clinical study with ALN-TTR01.